Hosted on MSN54m
Aclaris Therapeutics Unveils Promising Data on ATI-2138, a Novel Dual ITK/JAK3 Inhibitor
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced significant findings about ATI-2138, a novel investigational drug ...
Lung cancer cells can go 'off grid' and develop their own electrical network within the tumor, study shows
Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...